Basic Information
Samsung BioLogics is a world-class Contract Development and Manufacturing Organization (CDMO) dedicated to the development and manufacturing of quality-driven biopharmaceutical products. Samsung BioLogics’ customer-centric business model supports collaborative development of novel drugs and high-quality, rapid-turnaround contract manufacturing partnerships. Samsung BioLogics’ cutting-edge facilities are built in compliance with global cGMP regulations. Samsung BioLogics will provide the infrastructure to establish partnerships with industry leaders for the development, refinement, and distribution of biopharmaceutical products on a global scale.
Samsung BioLogics Co. Ltd.
IncheonMetropolitanCity,SouthKorea
more than 500 people
April 01, 2011
--

